Control of cardiac hypertrophy by calcium/calmodulin. Cardiac hypertrophy is an adaptive ... M.C. & Marks, A.R. Inositol 1,4,5-trisphosphate receptor expression in cardiac myocytes. J. Cell ...

Researchers at UCSF Medical Center have begun enrollment for an early-stage clinical trial to evaluate the safety and efficacy of an adult stem cell therapy for patients who have just experienced ...

CaMKII, or Calcium and calmodulin-dependent protein kinase II, is critical to cardiomyocytes, the muscle cells of the heart, where it maintains the balance of calcium.

An off-the-shelf artificial cardiac patch improves cardiac repair after myocardial infarction in rats and pigs. Science Translational Medicine , 2020; 12 (538): eaat9683 DOI: 10.1126/scitranslmed ...

The researchers applied the FUCCI system to human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-cardiomyocytes) and measured their cell cycle activities during cardiac differentiation.

Cell therapy, involving adult stem cells from bone marrow, has been shown to reduce the risk of heart attack and stroke in severe heart failure patients, according to a new study.

Pittsburgh, PA - Scientists have developed new voltage-sensitive dyes that allow them to view and record cardiac action potentials from layers deep within the heart [1]. These new dyes will allow ...

Harvard and the Brigham call for more than 30 retractions of cardiac stem cell research. By Ivan Oransky and Adam Marcus Oct. 14, 2018. Reprints. Brigham and Women's Hospital in Boston.